Philips reports €4.4 billion in third-quarter sales
Comparable sales grew 3% and order intake rose 8% in the company’s Q3 2026 results.

Philips reported third-quarter 2026 sales of €4.4 billion on November 3. Comparable sales increased 3%, while order intake grew 8%, according to the company’s release.
Orders and recognized sales measure different stages of commercial activity. Higher order intake is not identical to current-quarter revenue and does not guarantee the timing of future delivery.
Context and evidence
The results provide a snapshot of corporate performance. They do not independently validate claims about any individual device’s clinical outcomes. The comparable sales measure should be distinguished from the absolute euro sales figure.
What it means
The figures point to commercial momentum, but product availability and hospital purchasing decisions remain separate questions. Readers should track how orders translate into delivery rather than treating them as already realized sales.
Primary source: Original announcement. This report is based on company statements, not an independent clinical assessment.
More from Corporate
AI illustrationMedtronic plans to acquire Contego Medical
The proposed acquisition deepens an existing vascular distribution partnership; an announcement is not a completed deal.
AI illustrationImaging growth leads Healthineers’ full-year results
Fiscal 2026 comparable revenue grew 4.0%, while diagnostics remained weaker.
AI illustrationSiemens Healthineers plans to become Healthineers
The proposed 2027 name change remains subject to the necessary approvals.